This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Commentaries

The Need for Theory in Addressing Nonadherence to Treatment

See article by De las Cuevas et al

This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

The Need for Theory in Addressing Nonadherence to Treatment

Nonadherence to prescribed medical treatment is a significant barrier to effective and efficient care and a difficult challenge to overcome.1 It has particularly tragic consequences in psychiatric care. Nonadherence can be defined as failure to follow treatment in part or in whole, with potential adverse consequences for the expected outcomes. Medication nonadherence has been estimated at 25%-30% for short-term medical therapies and about 50% for chronic medical conditions.2 Psychiatric care in particular is rendered significantly more complex and challenging due to poor adherence to treatment recommendations.3,4 Studies of patients receiving antipsychotic medications and patients on antidepressants showed adherence to prescribed treatment 58% (24%-90%) and 65% (40%-90%) of the time, respectively.5-7 As a result, patients and families suffer unnecessarily, and society shoulders additional and avoidable costs in an already inefficient system of care.1

In this issue of the Journal, De las Cuevas et al8 analyze the potential causes of patients’ nonadherence and, most importantly, root their study on theory-based models of control beliefs. The authors conclude that control beliefs correlate with adherence to psychiatric treatment, and their assessment should offer an opportunity for clinicians to understand and intervene.

Determinants of nonadherence can manifest themselves in the patient’s intent and behavior, as measured in part by control beliefs; in the process of care, such as provision and management of care; and in the structure of care delivery, such as financial, physical, behavioral, or cultural access. Determinants of nonadherence have a multiplicity of causes and require a methodical and focused approach.5 Adherence to medical treatment recommendations seems to be correlated with the severity of the disease, with higher compliance in more threatening and acute conditions, and is associated with a significant drop after 6 months of chronic conditions.9 Psychotropic medication polypharmacy continues to be a major issue related to poor adherence.10,11

A recent review7 of the literature addressing medication adherence interventions yielded relatively modest and disappointing outcomes. A few recent developments12 offer some hope with practical interventions, but few theoretical explanations are available. Medical homes and case or disease-management teams, for example, are modestly effective at increasing medication compliance in chronic conditions.

In a review of the current approaches to nonadherence in medical care, van Dulmen et al9 identified several categories of interventions: technical (simplifying the medication regimen), behavioral (reminders, monitoring, rewards), educational (didactic), social supportive (assertive community teams), structural (work place interventions), and complex (multiple interventions). Four interventions yielded modest effects: technical (mostly simplifying the dosage and packaging), behavioral, educational, and multifaceted, results that leave the field with an invitation to trial-and-error methodologies based on little theoretical basis. Replicating intuitive and pragmatic methodologies, an adopt-or-adapt approach, has not resulted in any significant understanding of the critical variables. The lack of theoretical models, the modest outcomes, and the difficulties in replicability raise the questions of what works and why.

De las Cuevas and colleagues8 propose theory-based interventions to improve medication adherence that would allow for identification of determinants, replication, and efficient implementations. The authors use several social psychology theories to investigate control beliefs related to patient’s adherence to treatment. For example, they investigate, in part, the potential role of the Health Belief Model, a theory of health behavior, on psychiatric patient adherence to treatment.8 The model is based on an individual’s beliefs and attitudes that determine the likelihood of whether he or she will engage in health-promoting behaviors. The model states that if an individual is at risk of a severe negative outcome, thinks that he or she is a likely target of health-promoting behavior, thinks that specific behaviors can decrease the severity of the outcome, and thinks that the challenges faced when engaging in the specific behaviors are surmountable, then the individual is likely to engage in those behaviors.13 A cue is also necessary to trigger the health-promoting behavior. This model has been used to analyze medical regimen adherence.14

Theory-based models can, and must, be used to identify nonadherence attitude and behaviors and to provide focused, preventive, and remedial methodologies in the clinical setting. Using theory and evidence to understand and intervene is at the core of medical as well as psychiatric care. If psychopharmacologic interventions are rooted in theory-based clinical trials, why should treatment adherence be exempt from rigorous theory-based scientific studies that lead to targeted approaches?

Similarly, the puzzling resistance of clinicians and delays in adopting evidence-based practices is well documented.15,16 While the evidence is often quite clear and uncontroversial, multiple efforts at implementation have yielded modest progress, mostly based on prescriptive, empirical, and pragmatic interventions that are not rooted in a particular theory.17 Efforts are underway to analyze barriers to clinicians’ implementation of evidence-based medicine based on well-studied social psychological models.18 Since multiple theories of individual and organizational behavior exist, a tool was developed to provide consensus and validation in theories relating to clinicians behaviors. The Theoretical Domains Framework provides 12 domains: knowledge; skills; social/professional role and identity; beliefs about capabilities; beliefs about consequences; motivation and goals; memory, attention, and decision processes; environmental context and resources; social influences; emotion regulation; behavioral regulation; and nature of the behaviors.19 The domains are used to explain behavior changes in the implementation research and its applications.

Using a pragmatic armamentarium to remedy nonadherence to treatment or evidenced-based medicine without fundamental understanding of behavior determinants is inefficient at best. This is why, over 150 years after Ignaz Philipp Semmelweis discovered that the most likely cause of postpartum puerperal fevers was clinicians’ poor hand hygiene, we are still frustrated at clinicians’ failure to fully comply with basic infection avoidance protocols.

If science insists on use of empirical data to develop theories that can be demonstrated or rejected based on experimentation, then much work remains to be done to understand and counteract patients’ and clinicians’ nonadherence. Some efforts have been made in behavioral health,20-22 but they have drawn relatively little attention. We might consider heeding Sir William Osler’s admonition: "The good physician treats the disease; the great physician treats the patient who has the disease."

Potential conflicts of interest: None reported.

Funding/support: None reported.

REFERENCES

1. Iuga AO, McGuire MJ. Adherence and health care costs. Risk Manag Healthc Policy. 2014;7:35-44. PubMed

2. Haynes RB, Yao X, Degani A, et al. Interventions to enhance medication adherence. Cochrane Database Syst Rev. 2005;(4):CD000011. PubMed

3. Kane JM. Improving treatment adherence in patients with schizophrenia. J Clin Psychiatry. 2011;72(9):e28. PubMed doi:10.4088/JCP.9101tx2c

4. Velligan DI, Weiden PJ, Sajatovic M, et al; Expert Consensus Panel on Adherence Problems in Serious and Persistent Mental Illness. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry. 2009;70(suppl 4):1-46, quiz 47-48. PubMed doi:10.4088/JCP.7090su1cj

5. Nieuwlaat R, Wilczynski N, Navarro T, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;(11):CD000011. PubMed

6. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA. 2002;288(22):2868-2879. PubMed doi:10.1001/jama.288.22.2868

7. Viswanathan M, Golin CE, Jones CD, et al. Medication Adherence interventions: comparative effectiveness closing the quality gap: revisiting the state of the science. AHRQ Publication No. 12-E010. Agency for Healthcare Research and Quality Web site. https://www.effectivehealthcare.ahrq.gov/ehc/products/296/1248/
EvidenceReport208_CQGMedAdherence_FinalReport_20120905.pdf
. September 2012.

8. De las Cuevas C, Peñate W, Cabera C. Perceived health control: a promising step forward in our understanding of treatment adherence in psychiatric care. J Clin Psychiatry. 2016;77(10):e1233-e1239.

9. van Dulmen S, Sluijs E, van Dijk L, et al. Patient adherence to medical treatment: a review of reviews. BMC Health Serv Res. 2007;7(1):55. PubMed doi:10.1186/1472-6963-7-55

10. Fisher MD, Reilly K, Isenberg K, et al. Antipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapy. BMC Psychiatry. 2014;14(1):341. PubMed doi:10.1186/s12888-014-0341-5

11. Tiihonen J, Suokas JT, Suvisaari JM, et al. Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia. Arch Gen Psychiatry. 2012;69(5):476-483. PubMed doi:10.1001/archgenpsychiatry.2011.1532

12. Beadles CA, Farley JF, Ellis AR, et al. Do medical homes increase medication adherence for persons with multiple chronic conditions? Med Care. 2015;53(2):168-176. PubMed doi:10.1097/MLR.0000000000000292

13. Carpenter CJ. A meta-analysis of the effectiveness of Health Belief Model variables in predicting behavior. Health Commun. 2010;25(8):661-669. PubMed doi:10.1080/10410236.2010.521906

14. Janz NK, Becker MH. The Health Belief Model: a decade later. Health Educ Q. 1984;11(1):1-47. PubMed doi:10.1177/109019818401100101

15. Pope C. Resisting evidence: the study of evidence-based medicine as a contemporary social movement. Health. 2003;7(3):267-282. doi:10.1177/1363459303007003002

16. Porta M. Is there life after evidence-based medicine? J Eval Clin Pract. 2004;10(2):147-152. PubMed doi:10.1111/j.1365-2753.2003.00473.x

17. Michie S, Fixsen D, Grimshaw JM, et al. Specifying and reporting complex behaviour change interventions: the need for a scientific method. Implement Sci. 2009;4(1):40. PubMed doi:10.1186/1748-5908-4-40

18. French SD, Green SE, O’ Connor DA, et al. Developing theory-informed behaviour change interventions to implement evidence into practice: a systematic approach using the Theoretical Domains Framework. Implement Sci. 2012;7(1):38. PubMed doi:10.1186/1748-5908-7-38

19. Michie S, Johnston M, Abraham C, et al; "Psychological Theory" Group. Making psychological theory useful for implementing evidence based practice: a consensus approach. Qual Saf Health Care. 2005;14(1):26-33. PubMed doi:10.1136/qshc.2004.011155

20. Casper ES. The theory of planned behavior applied to continuing education for mental health professionals. Psychiatr Serv. 2007;58(10):1324-1329. PubMed doi:10.1176/ps.2007.58.10.1324

21. Casper ES. Using implementation intentions to teach practitioners: changing practice behaviors via continuing education. Psychiatr Serv. 2008;59(7):747-752. PubMed doi:10.1176/ps.2008.59.7.747

22. Perkins MB, Jensen PS, Jaccard J, et al. Applying theory-driven approaches to understanding and modifying clinicians’ behavior: what do we know? Psychiatr Serv. 2007;58(3):342-348. PubMed doi:10.1176/ps.2007.58.3.342

aJMS Consulting, Tucson, Arizona

*Corresponding author: José M Santiago, MD, 5112 N Via Condesa, Tucson, AZ 85718 (jsantiago01@earthlink.net).

J Clin Psychiatry 2016;77(10):e1348-e1349

dx.doi.org/10.4088/JCP.15com10494

© Copyright 2016 Physicians Postgraduate Press, Inc.

Related Articles

Volume: 77

Quick Links: Psychiatry

References